𝐅𝐢𝐥𝐥 𝐅𝐢𝐧𝐢𝐬𝐡 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐨𝐫𝐭𝐡 $25.7 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2029
Download PDF Brochure @ https://lnkd.in/djuC9B_u
The size of global 𝐟𝐢𝐥𝐥 𝐟𝐢𝐧𝐢𝐬𝐡 𝐦𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐧 𝐭𝐞𝐫𝐦𝐬 𝐨𝐟 𝐫𝐞𝐯𝐞𝐧𝐮𝐞 𝐰𝐚𝐬 𝐞𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐝 𝐭𝐨 𝐛𝐞 𝐰𝐨𝐫𝐭𝐡 $16.7 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2024 𝐚𝐧𝐝 𝐢𝐬 𝐩𝐨𝐢𝐬𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $25.7 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2029, 𝐠𝐫𝐨𝐰𝐢𝐧𝐠 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 8.9% from 2024 to 2029
This is mainly due to rise in the use of pre-filled syringes for parenteral dosages, growing demand for #vaccines and #biologics and increasing #pharmaceutical and #biotechnology applications. However, high operational costs are predicted to cause market growth barriers.
#Europe 𝐚𝐜𝐜𝐨𝐮𝐧𝐭𝐞𝐝 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐥𝐚𝐫𝐠𝐞𝐬𝐭 𝐬𝐡𝐚𝐫𝐞 𝐨𝐟 36.3% 𝐨𝐟 𝐭𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐅𝐢𝐥𝐥 𝐟𝐢𝐧𝐢𝐬𝐡 𝐦𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭, 𝐟𝐨𝐥𝐥𝐨𝐰𝐞𝐝 𝐛𝐲 #NorthAmerica and the #AsiaPacific, 𝐰𝐢𝐭𝐡 𝐬𝐡𝐚𝐫𝐞𝐬 𝐨𝐟 33.2% 𝐚𝐧𝐝 24.9%, 𝐫𝐞𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞𝐥𝐲. The key factors driving market growth are established pharmaceutical industry, strategic location and infrastructure, and a collaborative ecosystem. The market in the 𝐀𝐬𝐢𝐚 𝐏𝐚𝐜𝐢𝐟𝐢𝐜 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐰𝐢𝐭𝐧𝐞𝐬𝐬 𝐭𝐡𝐞 𝐡𝐢𝐠𝐡𝐞𝐬𝐭 𝐠𝐫𝐨𝐰𝐭𝐡 𝐫𝐚𝐭𝐞 𝐨𝐟 9.5% during the forecast period, primarily due to the increasing adoption of self-administration and expansion initiatives by key players such as construction of new manufacturing facilities, capacity expansions, and investments in state-of-the-art equipment and technologies.
𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞:
Makat Candy Technology GmbH a Syntegon company , I.M.V. S.P.A., BD, West Pharmaceutical Services, Gerresheimer , AptarGroup S.A., Datwyler Holding AG, Berry Global, Inc. , Stevanato Group , OPTIMA packaging group , Bausch+Ströbel SE + Co. KG, groninger & co. gmbh , SGD Pharma , SCHOTT Pharma, Nipro Medical Corporation , BAUSCH Advanced Technology Group and MAQUINARIA INDUSTRIAL DARA SL
𝐄𝐧𝐭𝐞𝐫𝐩𝐫𝐢𝐬𝐞𝐬 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐰𝐢𝐭𝐡𝐢𝐧 𝐭𝐡𝐢𝐬 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲:
Cangene bioPharma
Avrio Biopharmaceuticals
Cephazone Pharma LLC
Projectleider bij Unica Industry Solutions
1moPieter veel succes met de beurs